ASHISH KUMAR PARASHAR

Dr. ASHISH KUMAR PARASHAR

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2024 in Discover Oncology
Verified
Journal Article
Open access
PDF file
ASHISH KUMAR PARASHARASHISH KUMAR PARASHAR
ASHISH KUMAR PARASHAR
SPSri Kant Pharmacy
Sri Kant Pharmacy
PJPushpendra Kumar Jain
Pushpendra Kumar Jain
BKBalak Das Kurmi
Balak Das Kurmi
VSVivek Shrivastava
Vivek Shrivastava
VAVandana Arora
Vandana Arora
Nanotheranostics, an amalgamation of therapeutic and diagnostic capabilities at the nanoscale, is revolutionizing personalized medicine. Polymer-drug conjugates (PDCs) stand at the forefront of this arena, offering a multifaceted approach to treat complex diseases such as cancer. This review explores the recent advancements in PDCs, highlighting their design principles, working mechanisms, and the therapeutic applications. We discuss the incorporation of imaging agents into PDCs that allow for real-time monitoring of drug delivery and treatment efficacy. With the aim of improving patient care, the review examines how PDCs enable targeted drug delivery, minimize side effects, and provide valuable diagnostic data, hence enhancing the precision of medical interventions. We also address the challenges facing the clinical translation of PDCs, such as scalability, regulatory hurdles, and cost-effectiveness, providing a comprehensive outlook on the future of nanotheranostics in patient management.

31 October 2025 in Discover Food
Verified
Journal Article
Open access
PDF file
PJPushpendra Kumar Jain
Pushpendra Kumar Jain
ASHISH KUMAR PARASHARASHISH KUMAR PARASHAR
ASHISH KUMAR PARASHAR
VSVivek Shrivastava
Vivek Shrivastava
Polyphenols are a diverse and widely distributed group of plant-derived phytochemicals known for their broad spectrum of biological activities. Found abundantly in fruits, vegetables, grains, tea, coffee, and wine, these compounds are increasingly recognized for their significant contribution to human health. Their benefits are largely attributed to potent antioxidant, anti-inflammatory, and bioactive properties, which support the prevention and management of chronic diseases. Among their many functions, polyphenols serve as powerful antioxidants, capable of neutralizing reactive oxygen species (ROS) and reducing oxidative stress a key contributor to the development of degenerative diseases such as cancer, cardiovascular conditions, and neurodegenerative disorders including Alzheimer’s and Parkinson’s disease. This review explores the classification of polyphenols based on their chemical structures, their major dietary sources, and their bioavailability and metabolism, which influence their biological efficacy. In addition to their antioxidant potential, polyphenols exhibit a wide range of therapeutic activities, including anti-inflammatory, anti-cancer, cardioprotective, and neuroprotective effects. The review also discusses current challenges in optimizing the health benefits of polyphenols, including limited bioavailability, interactions with other dietary components, and variability in individual metabolism. Finally, future research directions are proposed, emphasizing advanced delivery systems, functional food applications, and integrated clinical studies using tools such as metabolomics and nutrigenomics. AbstractSection Graphical Abstract

1 September 2023 in Recent Advances in Drug Delivery and Formulation
Verified
Journal Article
Closed access
PDF file
ASHISH KUMAR PARASHARASHISH KUMAR PARASHAR
ASHISH KUMAR PARASHAR
KVKrishna Kumar Verma
Krishna Kumar Verma
RKRajeev Kumar
Rajeev Kumar
VAVandana Arora
Vandana Arora
For the last two decades, carbon dots, a revolutionary type of carbon nanomaterial with less than 10 nm diameter, have attracted considerable research interest. CDs exhibit various physicochemical properties and favorable characteristics, including excellent water solubility, unique optical properties, low cost, eco-friendliness, an abundance of reactive surface groups, and high stability. As a result, the synthesis of CDs and their applications in pharmaceutical and related disciplines have received increasing interest. Since CDs are biocompatible and biodegradable with low toxicity, they are a promising healthcare tool. CDs are extensively employed for numerous applications to date, including theranostics, bioimaging, drug delivery, biosensing, gene delivery, cancer therapy, electrochemical biosensing, and inflammatory treatment. This comprehensive review aims to explore various synthesis methods of carbon dots, including top-down and bottom-up approaches, as well as highlight the characterization techniques employed to assess their physicochemical and biological properties. Additionally, the review delves into carbon dots' pharmaceutical and biomedical applications, showcasing their potential in drug delivery, bioimaging, diagnostics, and therapeutics.

20 February 2025 in Bulletin of the National Research Centre
Verified
Journal Article
Open access
PDF file
ASHISH KUMAR PARASHARASHISH KUMAR PARASHAR
ASHISH KUMAR PARASHAR
GSGaurav Kant Saraogi
Gaurav Kant Saraogi
VSVivek Shrivastava
Vivek Shrivastava
RBRashmi Bagri
Rashmi Bagri
LTLalit Kumar Tyagi
Lalit Kumar Tyagi
PJPushpendra Kumar Jain
Pushpendra Kumar Jain
Background: Glioblastoma multiforme remains a challenging cancer to treat effectively. This study focuses on developing a novel nanotheranostic platform to improve targeted temozolomide delivery and enhance glioblastoma multiforme treatment. Results: This study successfully developed a multifunctional nanocarrier system utilizing fourth-generation polypropylene imine (PPI) dendrimers, functionalized with polyethylene glycol (PEG) for enhanced biocompatibility and conjugated with Angiopep-2 (ANG-2) for targeted delivery to glioblastoma multiforme cells. Incorporating silver sulfide (Ag2S) quantum dots conferred near-infrared (NIR) imaging capabilities, enabling noninvasive real-time monitoring. Comprehensive characterization using FTIR, NMR, and mass spectrometry validated the successful synthesis, functionalization, and encapsulation of the nanocarrier, with evidence of efficient loading of temozolomide (TMZ) at 56.32 ± 2.8%. In vitro drug release studies demonstrated a sustained release profile, achieving 52.86 ± 2.09% release within 24 h. Ex vivo studies revealed significantly enhanced cellular uptake and cytotoxicity against BCECs and C6 glioma cells compared to free TMZ, while in vivo biodistribution studies confirmed targeted accumulation of the nanocarrier in tumor tissues, as visualized through NIR imaging. Conclusions: This study highlights the significant potential of the developed dendrimer-based nanotheranostic system as an innovative platform for glioblastoma multiforme treatment. The successful integration of fourth-generation PPI dendrimers, PEG functionalization, ANG-2 targeting ligands, and Ag2S quantum dots enabled precise imaging-guided delivery and targeted temozolomide therapy. The system demonstrated excellent biocompatibility, high drug-loading capacity, sustained drug release, enhanced cellular uptake, and tumor-specific accumulation, translating into superior therapeutic efficacy and real-time imaging capabilities. These findings highlight the promise of this multifunctional nanoplatform in addressing the challenges of glioblastoma therapy and pave the way for future clinical translation in personalized cancer treatment.

27 May 2025 in Current Gene Therapy
Verified
Journal Article
Closed access
PDF file
ASHISH KUMAR PARASHARASHISH KUMAR PARASHAR
ASHISH KUMAR PARASHAR
AHAnu Hardenia
Anu Hardenia
SDSunil Kumar Dwivedi
Sunil Kumar Dwivedi
GSGaurav Kant Saraogi
Gaurav Kant Saraogi
SHShiv Hardenia
Shiv Hardenia
The increasing approval of nucleic acid therapeutics has led to a significant advancement in medicines, demonstrating their potential to revolutionize the prevention and treatment of numerous diseases. However, challenges like nuclease degradation and difficult cellular delivery hinder their use as therapeutic agents. The rising demand for precise gene therapy delivery has positioned nanobiosystems as a groundbreaking solution, with their customizable properties enabling targeted and efficient delivery. Nucleic Acid therapeutics, encompassing antisense DNA, mRNA, small interfering RNA (siRNA), and microRNA (miRNA), have been rigorously investigated for their capacity to modulate gene expression. Notably, integrating these gene therapies with nanoscale delivery platforms has significantly broadened their scope, facilitating sophisticated advancements in bioanalysis, gene silencing, protein replacement therapies, and the development of vaccines. This review provides a thorough review of recent advancements in nanobiosystems for therapeutic nucleic acid delivery. We explore the unique characteristics of various nanobiosystems, including gene therapy-based delivery, nanoparticles, stimuli-responsive systems, smart nanocarriers, and extracellular vesicle-based delivery. We offer a detailed overview of their applications in nucleic acid delivery. Furthermore, we address biological barriers and strategies for the therapeutic delivery of nucleic acids. Ultimately, this review provides critical insights into the strategic development of nextgeneration delivery vectors for nucleic acid therapeutics.

1 November 2025 in Current Cancer Therapy Reviews
Verified
Journal Article
Closed access
PDF file
ASHISH KUMAR PARASHARASHISH KUMAR PARASHAR
ASHISH KUMAR PARASHAR
LTLalit Kumar Tyagi
Lalit Kumar Tyagi
VAVandana Arora
Vandana Arora
Histotripsy is an innovative non-invasive modality utilizing high-intensity focused ultrasound to induce mechanical tissue disruption via controlled cavitation. It represents a promising approach in oncology, offering a targeted alternative to conventional cancer therapies. The method relies on precise acoustic energy to create microbubbles that implode, causing cellular destruction within the targeted area while sparing surrounding tissues. In this review, we have explored the foundational principles underlying histotripsy, outlining how it leverages the physics of sound and cavitation to achieve precise tissue disruption. We have delved into the specific mechanisms by which histotripsy induces cell death. This review provides an overview of the current clinical applications of histotripsy in the treatment of various cancers, highlighting its benefits and the clinical outcomes reported thus far. Further, the review examines the breadth of ongoing research related to histotripsy. Looking to the future, the review discusses the promising implications of histotripsy for revolutionizing cancer care.